NDC 70594-117-01 - Bupivacaine HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-117
- Requested NDC
- 70594-117-01
- Package NDCs from labels
- 70594-117-01, 70594-117-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC
- Effective date
- 2023-06-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupivacaine HCl - Xellia Pharmaceuticals USA LLC | Xellia Pharmaceuticals USA LLC | 2023-06-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70594-117-01 | Bupivacaine HCl | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 2 | |
| 70594-117-02 | Bupivacaine HCl | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70594-117 | BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION BUPIVACINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [XELLIA PHARMACEUTICALS USA LLC] | 2 | Current NDC, 2 package rows | 20230622_f29c905e-9a55-446f-a89d-860ad9ade7ad.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-117-01 | ML - Milliliter | 70594-117 | 2feb9562-35c1-4637-931e-9f2fbd531c6a | 1 | 2023-08-08 |
| 70594-117-02 | ML - Milliliter | 70594-117 | 76e4c81c-6b22-4365-85ea-1c7bc2ea9661 | 1 | 2023-08-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sensorcaine MPF | BUPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | e700eb7b-8b14-49c9-96b2-331f18776e45 | 2023-05-12 | Boxed warning, Warnings, Adverse reactions | 1724880 1725078 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ada6a9bf-f7cb-035a-e053-2a95a90a6a3d | 2023-05-03 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d1642239-4230-b679-e053-2a95a90a3b7c | 2023-05-02 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| SENSORCAINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb | 2023-04-30 | Boxed warning, Warnings, Adverse reactions | 1724787 1724786 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | a60303c2-5217-41db-855b-83fa2a749da2 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 1724880 7TQO7W3VT8 |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175 | 2022-08-17 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1725078 1725082 7TQO7W3VT8 |
| BUPIVICAINE HYDROCHLORIDE | BUPIVICAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 99857946-6084-1bbd-e053-2a95a90af58c | 2020-10-06 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | 3eefbefe-78ae-4f2d-9be6-3f79eadcff86 | 2020-04-09 | Boxed warning, Warnings, Adverse reactions | 1725078 7TQO7W3VT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.